RIVNHIGH SIGNALFINANCIAL10-K

Rivian's financial position deteriorated significantly with stockholders' equity declining 33.8% to $9.1B while current liabilities surged 64.1% to $3.7B, creating potential liquidity concerns despite improved operating performance.

The substantial increase in current liabilities combined with declining cash reserves and reduced stockholders' equity signals mounting financial pressure that could constrain operations and growth investments. While operating cash flow improved meaningfully and losses narrowed, the balance sheet deterioration suggests Rivian may need external financing or face operational constraints in the near term.

Comparing 2026-02-12 vs 2025-02-24View on EDGAR →
FINANCIAL ANALYSIS

Rivian's 2025 results present a mixed picture with operational improvements overshadowed by balance sheet concerns. The company meaningfully reduced operating losses from $4.7B to $3.6B and substantially improved operating cash flow, while also increasing capital expenditures to $1.7B indicating continued growth investments. However, the financial position weakened considerably with stockholders' equity declining by over $4B, current liabilities increasing 64.1%, and cash reserves falling 32.4% to $3.6B, creating potential near-term liquidity challenges despite the operational progress.

FINANCIAL STATEMENT CHANGES
Current Liabilities
Balance Sheet
+64.1%
$2.3B→$3.7B

Current liabilities surged 64.1% — significant near-term obligations; verify ability to meet short-term debt.

Operating Cash Flow
Cash Flow
+54.6%
-$1.7B→-$779.0M

Operating cash flow surged 54.6% — exceptional cash generation, highest quality earnings signal.

Capital Expenditure
Cash Flow
+49.9%
$1.1B→$1.7B

Capital expenditure jumped 49.9% — major investment cycle underway; assess returns on deployment.

Stockholders Equity
Balance Sheet
-33.8%
$13.8B→$9.1B

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

Cash & Equivalents
Balance Sheet
-32.4%
$5.3B→$3.6B

Cash declined 32.4% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Inventory
Balance Sheet
-29.1%
$2.2B→$1.6B

Inventory reduced 29.1% — lean inventory management or demand outpacing supply.

Accounts Receivable
Balance Sheet
+25.3%
$443.0M→$555.0M

Receivables grew 25.3% — monitor days sales outstanding for collection efficiency.

Operating Income
P&L
+23.5%
-$4.7B→-$3.6B

Operating income improving — cost discipline or growing revenue base absorbing fixed costs.

Net Income
P&L
+23.2%
-$4.7B→-$3.6B

Net income grew 23.2% — bottom-line growth signals improving overall business health.

Current Assets
Balance Sheet
-18.8%
$10.6B→$8.6B

Current assets declined 18.8% — monitor working capital adequacy and short-term liquidity.

LANGUAGE CHANGES
NEW — 2026-02-12
PRIOR — 2025-02-24
ADDED
rivn-20251231 0001874178 2025 FY false Rivian Automotive, Inc.
As of January 29, 2026, 1,237,077,289 shares of the registrant's Class A common stock were outstanding, and 3,912,500 shares of the registrant's Class B common stock were outstanding.
Management's Discussion and Analysis of Financial Condition and Results of Operations 57 Item 7A.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 112 Item 13.
Form 10-K Summary 117 Signatures 118 1 RIVIAN AUTOMOTIVE, INC.
The automotive and value added software and services markets in which we operate are highly competitive, and we may not be successful in competing in these markets.
We must continue to develop complex software and hardware in coordination with the Joint Venture and our other vendors and suppliers to reach mass production for our vehicles, and there can be no assurance such systems will be successfully developed or integrated on a timely basis or at all, or perform effectively once integrated.
We are subject to risks associated with our joint venture with Volkswagen Group , including that a significant portion of our software and services revenues has been from Volkswagen Group.
If the Joint Venture does not meet its operational objectives, or we do not achieve the anticipated incremental benefits and future revenue opportunities as a result of the Joint Venture then our business, prospects, financial condition, results of operations, and cash flows could be materially and adversely affected.
We have experienced, and could experience in the future, cost increases and disruptions in supply of raw materials, components or equipment used to produce our vehicles.
REMOVED
rivn-20241231 0001874178 2024 FY false Rivian Automotive, Inc.
As of February 14, 2025, 1,122,889,465 shares of the registrant's Class A common stock were outstanding, and 7,825,000 shares of the registrant's Class B common stock were outstanding.
Management's Discussion and Analysis of Financial Condition and Results of Operations 61 Item 7A.
Security Ownership of Certain Beneficial Owner and Management and Related Stockholder Matters 111 Item 13.
Form 10-K Summary 116 Signatures 117 1 RIVIAN AUTOMOTIVE, INC.
Forward-looking statements contained in this Form 10-K include, but are not limited to statements regarding our future results of operations and financial position, industry and business trends, business strategy, plans, market growth, regulatory and political environment, and objectives relating to our climate commitment, and our objectives for future operations.
Our future success depends on growing the sales of our commercial vehicles and securing additional commercial agreements with businesses.
The automotive market is highly competitive, and we may not be successful in competing in this industry.
We are subject to risks associated with our joint venture with the Volkswagen Group.
We have experienced, and could experience in the future, cost increases and disruptions in supply of raw materials or other components used in our vehicles.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →